文献速递细菌感染、耐药与抗菌药物真菌感染结核与非结核分枝杆菌

免疫功能低下患者社区获得性肺炎的患病率与病因学

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients.
PubMed 文献 · Clin Infect Dis · 2019-01-01

该研究为国际多中心研究的二次分析,纳入54国222家医院3702例社区获得性肺炎住院成人。18%存在至少1项免疫抑制危险因素,以慢性激素使用(45%)、血液系统肿瘤(25%)和化疗(22%)最常见。免疫抑制患者CAP病原谱与免疫正常者无差异,但特定因素与真菌、分枝杆菌及非流感病毒感染独立相关。

要点

  • 免疫抑制患者CAP病原谱与免疫正常者相似,经验性抗菌治疗可参考CAP指南。
  • AIDS和血液系统肿瘤患者需警惕真菌、分枝杆菌及非流感病毒感染。
  • 免疫抑制危险因素分布存在显著地域差异。

核心结论

  • 免疫抑制患者CAP病原谱与免疫正常者无差异,经验性抗生素治疗可参考CAP指南。
  • AIDS和血液系统肿瘤患者因CAP住院时真菌、分枝杆菌及非流感病毒感染比例可能更高。

研究设计与样本

  • 国际多中心研究的二次分析,纳入54国222家医院3702例社区获得性肺炎住院成人。

主要发现

  • 18%患者存在至少1项免疫抑制危险因素。
  • 最常见危险因素为慢性激素使用(45%)、血液系统肿瘤(25%)和化疗(22%)。
  • 免疫抑制患者CAP病原体最常见,且与免疫正常者无差异。
  • 免疫抑制危险因素与铜绿假单胞菌或非社区获得性细菌无独立关联。
  • AIDS与真菌感染独立相关(OR 15.10,P=.001),血液系统肿瘤OR 4.65(P=.001);AIDS与分枝杆菌感染相关(P=.006);血液系统肿瘤与非流感病毒感染相关(OR 5.49,P<.001)。

临床怎么用

  • 经验性抗生素治疗CAP时,免疫抑制状态不应常规覆盖铜绿假单胞菌或非社区获得性细菌。
  • AIDS或血液系统肿瘤患者因CAP住院时,应考虑真菌、分枝杆菌及非流感病毒感染的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. METHODS: We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. RESULTS: At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non-community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P < .001). CONCLUSIONS: Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Di Pasquale MF, Sotgiu G, Gramegna A, et al. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients. Clin Infect Dis. 2019. PMID: 31222287. doi:10.1093/cid/ciy723

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。